Skip to Main Content

234

Views

13

CrossRef citations to date

0

Altmetric

Original Articles

Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis

Yuanhua QinDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China; ;Department of Parasitology, Dalian Medical University, Dalian, China; View further author information

,

Weifeng MaoDepartment of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China;

http://orcid.org/0000-0002-8632-1942 View further author information

,

Lingmin PanDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Yunliang SunDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Fushun FanDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Ying ZhaoLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Ying CuiLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Xiaoqing WeiLiaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China; View further author information

,

Kazuhiro KohamaResearch Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo, Japan; View further author information

,

Fang LiDepartment of Immunology, Dalian Medical University, Dalian, ChinaCorrespondence[email protected]
View further author information

&

Ying GaoDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China; ;Liaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China; Correspondence[email protected]
View further author information

Abstract

Context: Atherosclerosis is a chronic inflammatory disease in which the plaques were built up inside of the artery. Interleukin-8 (IL-8, CXCL8) is an inflammatory factor, known to play an important role in the development of atherosclerosis. G31P is an antagonist of the IL-8 receptor, which plays roles in vascular smooth muscle cell (VSMC) proliferation and migration.

Objective: This study is to investigate the therapeutic effect of G31P on atherosclerosis through a mouse model.

Materials and methods: A mouse model of atherosclerosis was generated through feeding the ApoE^–/– mice with high fat diet for 12 weeks. G31P was injected subcutaneously into the mice. The levels of keratinocyte chemoattractant (KC), CXCR2, TNF-α, and IFN-γ were analyzed through ELISA. The expressions of MMP-2, MMP-9, PCNA, and Mef2a in aortic tissues were detected through RT-qPCR. In A7r5 cells, the levels of p-ERK, ROCK1, and ROCK2 were analyzed by western blot. Intracellular calcium levels were measured through Fluo-3 AM assay.

Results and disccussion: G31P suppressed the abnormal lipid profile and decreased the levels of KC, MMP-2, MMP-9, PCNA, and Mef2a in a mouse model of atherosclerosis. In addition, G31P also inhibited the expressions of p-ERK, ROCK1, ROCK2, and decreased the calcium concentrations in A7r5 cells.

Conclusions: These findings indicate the potential therapeutic effects of G31P in suppressing the development of atherosclerosis by antagonizing the IL-8 receptor. G31P inhibits the proliferation and migration of VSMCs through regulating the Rho-kinase, ERK, and calcium-dependent pathways.

Keywords:

Disclosure statement

The authors do not have any conflict of interest about this paper.

Additional information

Funding

This study was supported by grants from the National Science Foundation of China (30470394, 31070719, 31370800, and 81402916) and the grants from Liaoning Province (20072166, 2009A195, 2013023015, and 20180530056).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.